Researchers from UCLA have found a promising new way to help men with recurring prostate cancer live longer without their ...

Enzalutamide plus leuprolide reduces the risk of death by more than 40% in biochemically recurrent prostate cancer compared to leuprolide alone.

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...

Melanie was stage 4” her doctor said of her, where she “was one of those rare cases of stage 4 breast cancer that was curable." ...

Grape seed extract—a dietary supplement made from the seeds of wine grapes—has been investigated to see if it can help reduce ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...

Montell Jordan shared an update on his ongoing prostate cancer treatment, revealing he's documenting the journey while staying positive.

Former president Joe Biden completed a round of radiation therapy Monday, as part of his treatment for an aggressive form of ...

(HealthDay News) — Many people with cancer get directly involved in prior authorization (PA), often facing substantial time burdens, according to a study presented at the 2025 American Society of ...

Adding the drug enzalutamide to standard hormone therapy reduced deaths by more than 40% in men with recurrent prostate ...

Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive ...